According to Immunic's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 5.03 | 115.09% |
2023-12-31 | 2.34 | 328.49% |
2022-12-31 | 0.5463 | -72.36% |
2021-12-31 | 1.98 | -3.05% |
2020-12-31 | 2.04 | 14.14% |
2019-12-31 | 1.79 | 181.15% |
2018-12-31 | 0.6352 | -87.34% |
2017-12-31 | 5.02 | 110.37% |
2016-12-31 | 2.39 | -44.06% |
2015-12-31 | 4.26 | -30.42% |
2014-12-31 | 6.13 | |
2013-12-31 | N/A | |
2012-12-31 | N/A |